Palo Alto, CA, United States of America

Ying Liu

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 10.7

ph-index = 4

Forward Citations = 118(Granted Patents)


Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Ying Liu: Innovator in Antibody Development

Introduction

Ying Liu is a prominent inventor based in Palo Alto, California, known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, Liu has focused on developing novel antibodies that target specific deletion mutants of the epidermal growth factor receptor.

Latest Patents

One of Liu's latest patents is centered around antibodies directed to the deletion mutants of the epidermal growth factor receptor, particularly the type III deletion mutant known as EGFRvIII. This invention encompasses human monoclonal antibodies that are specifically designed to target these deletion mutants. Additionally, the patent includes diagnostic and therapeutic formulations of such antibodies, as well as immunoconjugates derived from them.

Career Highlights

Throughout his career, Ying Liu has worked with notable companies such as Amgen Fremont Inc. and Microsoft Technology Licensing, LLC. His work in these organizations has contributed to advancements in biotechnology and therapeutic development.

Collaborations

Liu has collaborated with esteemed colleagues, including Richard F. Weber and Xiao Feng, further enhancing the impact of his research and innovations.

Conclusion

Ying Liu's work in antibody development has positioned him as a key figure in biotechnology, with a focus on innovative solutions for targeting specific cancer-related mutations. His contributions continue to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…